Lipigon Pharmaceuticals

0,00 SEK

-13,79%

Mindre end 1K følgere

LPGO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lipigon Pharmaceuticals

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Omsætning1,310,3
EBITDA-6,7-11,1-25,5-9,1-8,5-7,4-7,2-32,1
EBIT-6,7-11,1-25,6-9,1-8,5-7,4-7,2-32,2
EBIT-%-840,2 %-248,6 %
Overskud før skat-6,7-10,7-25,3-9,2-8,7-7,4-7,2-32,4
Netto indkomst-6,7-10,7-25,3-9,2-8,7-7,4-7,2-32,4